{"slug":"tesamorelin-nerve-damage","verification":{"valid":true,"entries":2,"head":"79f378ca2f14f72cece708cdfb2510603a731f1faf79a60311b3d56a43eac46d"},"energy":{"passes":2,"tokens_in":35735,"tokens_out":3185,"tokens_total":38920,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"79f378ca2f14f72cece708cdfb2510603a731f1faf79a60311b3d56a43eac46d"},"provenance":[{"ts":"2026-06-29T23:18:59.978Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Nerve Damage\nSlug: tesamorelin-nerve-damage\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Tesamorelin** → GH axis / visceral fat\",\"section_headings\":[\"What's breaking down\",\"Why Tesamorelin might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one pe","response":"{\n  \"slug\": \"tesamorelin-nerve-damage\",\n  \"title\": \"Tesamorelin for Nerve Damage: Evidence Review\",\n  \"body\": \"## What's breaking down\\nNerve damage often involves axonal disruption after injury, followed by slow or incomplete regeneration. Denervated muscle can atrophy over time because it receives no signals to maintain mass and strength. Repair pathways rely on growth factors and hormones that support axon regrowth and prevent wasting. When these signals stay low, functional recovery stalls even after surgical repair. Degeneration outpaces repair in many cases, leaving persistent sensory loss, weakness, or pain. Tesamorelin fits into discussions of the GH axis because it raises growth hormone levels, and GH has been linked in lab models to better axon regrowth and less muscle loss.\\n\\n## Why Tesamorelin might help you\\n1. If your nerve injury leaves muscle without signals, GH elevation is discussed because animal work shows it can limit atrophy during the wait for reinnervation. 2. If axonal regrowth is the bottleneck, the same GH pathway is studied because it appears to support faster axon extension and better myelin thickness in rat models. 3. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain. It raises GH via the GHRH receptor, which in turn influences downstream factors tied to nerve and muscle maintenance.\\n\\n## How these fit together\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile. Tesamorelin targets the GH axis and its potential effects on visceral fat reduction alongside tissue repair signals. No other peptides are in scope here, so the discussion stays on how GH stimulation might intersect with nerve regeneration layers without overlapping essays on separate compounds.\\n\\n## What the evidence actually shows\\nHuman data: One ongoing randomized, double-blinded, place","tokens_in":35735,"tokens_out":3185,"cost":0,"prev":"genesis","hash":"ae92ddd7ac201fcad8229404583f2d6ee03184184a63745995dafa716d27ee9b"},{"ts":"2026-07-17T02:42:24.259Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-nerve-damage","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ae92ddd7ac201fcad8229404583f2d6ee03184184a63745995dafa716d27ee9b","hash":"79f378ca2f14f72cece708cdfb2510603a731f1faf79a60311b3d56a43eac46d"}]}